• AACP signed onto a Friends of HRSA FY23 Appropriations Request sent to House and Senate Appropriations Committees supporting increased funding for HRSA. AACP signed onto FASHP (Federation of Associations of Schools of the Health Professions) letter sent to House and Senate Appropriations leadership asking that they provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC) and $25 million for the National Institutes of Health (NIH) to conduct public health research into firearm morbidity and mortality prevention. AACP signed onto Coalition for Health Funding FY 2023 Labor-HHS-Ed 302(b) Organization Sign-on Letter sent to House and Senate Appropriations leadership. AACP signed onto letter sent by Research!America to House and Senate Appropriations leadership asking that they work towards securing a robust 302(b) funding allocation for the Labor-HHS-Education Subcommittee to meet the very real research funding needs before us. A healthy 302(b) allocation will help ensure robust funding for important health agencies in the Labor-HHS-Education Subcommittee including NIH, CDC, AHRQ, BARDA and ARPA-H.
• AACP joined FASHP Letter addressed to House and Senate leadership asking for passage of the Bipartisan Safer Communities Act, legislation that will take critical steps to curb the gun violence epidemic
• AACP signed onto letter from JCPP+ group to new czar Dr. Jha of The White House Coronavirus Task Force outlining pharmacist's priorities related to COVID-19 response. AACP signed onto letter led by FASHP to House and Senate leadership encouraging the inclusion of health professions education and training programs in your legislative efforts to address the mental health challenges facing our country. AACP signed onto letter sent to House and Senate leadership urging Congress to act and safeguard American's access to COVID-19 testing, treatments and vaccines and to prevent further dismantling of critical elements of our public health response. AACP signed onto National Pharmacy Associations COVID Vaccine Leadership Council letter to HHS asking for Clarification of Pharmacy PREP Act Authorities.

Duration: January 1, 2008 to June 30, 2022

General Issues: Budget/Appropriations, Firearms/Guns/Ammunition, Health Issues, Medicare/Medicaid, Immigration, Education, Indian/Native American Affairs, Government Issues, Taxation/Internal Revenue Code, Labor Issues/Antitrust/Workplace, Science/Technology, Medical/Disease Research/Clinical Labs, Agriculture

Spending: about $1,359,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, White House Office, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Justice - Dept of (DOJ), Homeland Security - Dept of (DHS), State - Dept of (DOS), Drug Enforcement Administration (DEA), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Indian Health Service, Education - Dept of, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), House of Representatives,